Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $836.7900 (1.69%) ($822.3400 - $836.7900) on Tue. Sep. 19, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.69% (three month average) | RSI | 53 | Latest Price | $836.7900(1.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Market Behavior | Value stocks sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(66%) IBB(60%) XLF(55%) DIA(54%) SDY(51%) | Factors Impacting REGN price | REGN will decline at least -0.845% in a week (0% probabilities). VXX(-45%) VIXM(-42%) TBT(-20%) USO(-18%) GLD(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.845% (StdDev 1.69%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $828.2(1.04%) | 10 Day Moving Average | $827.95(1.07%) | 20 Day Moving Average | $829.76(0.85%) | To recent high | -1% | To recent low | 20.9% | Market Cap | $88.724b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |